Avammune Therapeutics

Recent Finacing

Series A

Recent Raise

Undisclosed

Avammune Therapeutics is a Philadelphia-based drug discovery company developing systemically administered small-molecule modulators of the STING pathway for cancer treatment; spin-off from Aten Porus Lifesciences.

Founded 2017

Pennsylvania, United States

11-50

Private

avammune.com

Highlights

Focus Areas

Biotechnology

Therapeutics

Financials

1

Funding round

Team

Upgrade to view the team

See the team members at Avammune Therapeutics.